Alnylam Pharma Stock Outlook: Is ALNY Topping Out?

Alnylam Pharmaceuticals (Nasdaq: ALNY) is currently in Phase 10 of its 18-phase Adhishthana Cycle. With this phase scheduled to end in September 2025, the stock remains within its bullish structure. If that structure holds, the peak is likely to form in Phase 11, the classic culmination point of the Adhishthana Himalayan formation.

Read the full article on Benzinga for deeper insights into the Adhishthana Cycle, the stock’s recent trajectory, and expert commentary.